Get started
Author

Guoyan Qi

Observed names: Guo-Yan Qi, Qi Guoyan, Qi, Guoyan
ORCID: 0000-0001-9218-3219
Observed ORCID: 0000-0001-9218-3219
OpenAlex ID: A5040195066
Metagenome-wide association study of gut microbiome revealed potential microbial marker set for diagnosis of pediatric myasthenia gravis
2021 · Peng Liu, Yiqi Jiang, et al. · BMC Medicine · 57
PDF
Assessment of the risks of a myasthenic crisis after thymectomy in patients with myasthenia gravis: a systematic review and meta-analysis of 25 studies
2020 · Chaoying Liu, Peng Liu, et al. · Journal of Cardiothoracic Surgery · 39
PDF
Anti-BCMA/CD19 CAR T cell therapy in patients with refractory generalized myasthenia gravis: a single-arm, phase 1 trial
2025 · Yong Zhang, Dan Liu, et al. · EClinicalMedicine · 20
PDF
A Review of Advances in Mitochondrial Research in Cancer
2024 · Zhiru Li, Wu Zhang, et al. · Cancer Control · 17
BCMA/CD19 CAR T cell therapy for refractory myasthenia gravis: Proteomic signatures and single-cell transcriptomics of disease flares
2026 · Xiaoyu Huang, Zhouao Zhang, et al. · Science Advances · 15
PDF
Efficacy and safety of double-filtration plasmapheresis treatment of myasthenia gravis
2021 · Chaoying Liu, Peng Liu, et al. · Medicine · 15
The clinical absolute and relative scoring system—A quantitative scale measuring myasthenia gravis severity and outcome used in the traditional Chinese medicine
2014 · Guo-Chao Liu, Bu-Lang Gao, et al. · Complementary Therapies in Medicine · 15
Proteomics analysis of serum from thymoma patients
2023 · Jiaduo Li, Guoyan Qi, et al. · Scientific Reports · 11
PDF
Metastatic Thymoma-Associated Myasthenia Gravis: Favorable Response to Steroid Pulse Therapy Plus Immunosuppressive Agent
2017 · Guoyan Qi, Peng Liu, et al. · Medical Science Monitor · 11
PDF
Effects of combined traditional Chinese medicine with immunosuppressive agents for patients with myasthenia gravis.
2015 · Guoyan Qi, Shanshan Gu, et al. · PubMed · 8
Clinical features and HLA typing of immune checkpoint inhibitor-associated myasthenia gravis, myocarditis and myositis
2025 · Xiaoting Lin, Peng Liu, et al. · Frontiers in Oncology · 7
PDF
Factors associated with early response to efgartigimod in patients with generalized myasthenia gravis: a multicenter retrospective observational study
2025 · Wenjia Zhu, Yuping Chen, et al. · Journal of Neurology · 7
PDF
Serum amyloid A facilitates expansion of CD4 + T cell and CD19 + B cell subsets implicated in the severity of myasthenia gravis patients
2024 · Xiaoyu Huang, Xueting An, et al. · Journal of Neurochemistry · 6
Single-cell transcriptomics and network pharmacology reveal therapeutic targets of Jianpi Yiqi Bugan Yishen decoction in immune cell subsets of children with myasthenia gravis
2022 · Peng Liu, Guoyan Qi, et al. · Translational Pediatrics · 6
PDF
Observation on the efficacy of different methylprednisolone regimens in the treatment of myasthenia gravis
2022 · Xiaoting Lin, Guoyan Qi · Pakistan Journal of Medical Sciences · 6
PDF
Therapeutic Potential of Docetaxel plus Cisplatin Chemotherapy for Myasthenia Gravis Patients with Metastatic Thymoma
2017 · Guoyan Qi, Peng Liu, et al. · The Tohoku Journal of Experimental Medicine · 6
PDF
Exploring Potential Biomarkers of Early Thymoma based on Serum Proteomics
2023 · Min Jin, Peng Liu, et al. · Protein and Peptide Letters · 5
Identification of Potential Serum Protein Biomarkers in Thymoma with Myasthenia Gravis After Docetaxel Treatment
2023 · Hongxia Yang, Guoyan Qi, et al. · Neurology and Therapy · 5
PDF
Effect of Jianpiyiqi granule on ocular myasthenia gravis in children prepared with a formula from Traditional Chinese Medicine
2017 · Qi Guoyan, Liu Peng, et al. · 中医杂志：英文版 · 5
PDF
Developing and validating a nomogram to predict myasthenia gravis exacerbation in patients with postoperative thymoma recurrence
2022 · Biqi Cheng, Yinping Xue, et al. · Gland Surgery · 4
PDF
Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes
2017 · Guoyan Qi, Yinping Xue, et al. · Open Medicine · 4
PDF
Thymic characteristics in patients with autoimmune diseases: a multicentre radiological observational study
2025 · Haoxiao Chang, Junqiang Yan, et al. · The Lancet Regional Health - Western Pacific · 2
PDF
Development and External Validation of a Multivariable Model to Predict Early Minimal Symptom Expression Response in Adult Generalized Myasthenia Gravis Patients Treated With Efgartigimod
2026 · Yufang Yang, Tao Liang, et al. · CNS Neuroscience & Therapeutics · 1
PDF
Eculizumab as a new option for perioperative treatment in thymoma-associated myasthenia gravis
2025 · Hui Wu, Xianglin Chu, et al. · Clinical Immunology · 1
Efgartigimod Combined with Glucocorticoids in the Treatment of Severe Generalized Myasthenia Gravis: A Single-Center, Retrospective Cohort Study
2025 · Shanshan Gu, Yongzhao Li, et al. · Neurology and Therapy · 1
PDF
Works count: 39
Citation count: 275
H-index: 9
I10-index: 9
Year
Topic
Type